InjectionInjection
Schedule H (Prescription Required)Antiparkinson & Cognitive CareCode: 1557

Cerebroprotein Hydrolysate Injection 30mg

Generic Formulation:Cerebroprotein Hydrolysate Injection 30mg
Pack Size:1 vial
Jan Aushadhi MRP
₹187.5
Official Government Subsidized Price
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Cerebroprotein Hydrolysate is a purified porcine brain-derived peptide preparation containing neurotrophic factors and low-molecular-weight neuropeptides. It mimics the actions of endogenous neurotrophic factors (such as NGF and BDNF), crossing the blood-brain barrier to promote neuronal survival, stimulate neurite outgrowth, improve synaptic plasticity, and protect neurons against excitotoxicity and ischemic hypoxia. Indicated for acute ischemic stroke, traumatic brain injury, and vascular dementia.

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1557.Report inaccuracy

Usage Guidelines

Administered strictly by slow intravenous infusion diluted in Normal Saline, Ringer's solution, or 5% Dextrose over at least 60 minutes, or deep intramuscular injection by qualified clinical staff.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Mild headache, dizziness, sensation of warmth/sweating, nausea, injection site erythema. Rare/Severe: Severe hypersensitivity, hyperventilation, cardiac palpitations, and seizures in predisposed individuals.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in status epilepticus, severe renal failure, and hypersensitivity to porcine-derived biological products. Rapid IV infusion must be avoided to prevent sensations of heat, sweating, and dizziness.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.